Mark Waer - Publications

3-nitropyridine analogues as novel microtubule-targeting agents.

Journal: PloS one

Published: January 30, 2024

Synthesis of mizoribine prodrugs and their in vivo evaluation as immunosuppressive agents.

Journal: Bioorganic & medicinal chemistry letters

Published: August 07, 2023

Establishment of operational tolerance to sustain antitumor immunotherapy.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: August 05, 2021

Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes.

Journal: Frontiers in immunology

Published: January 07, 2021

Immunization with alloantibodies-covered melanoma cells induces regional antitumor effects that become systemic when combined with 5-FU treatment.

Journal: Cancer letters

Published: August 04, 2020

Intratumoral immunotherapy with anti-PD-1 and TLR9 agonist induces systemic antitumor immunity without accelerating rejection of cardiac allografts.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: January 07, 2020

Improved Anti-Tumour Adaptive Immunity Can Overcome the Melanoma Immunosuppressive Tumour Microenvironment.

Journal: Cancers

Published: October 20, 2019

Donor Lymphocyte-Derived Natural Killer Cells Control MHC Class I-Negative Melanoma.

Journal: Cancer immunology research

Published: August 30, 2019

Solid Tumor-Induced Immune Regulation Alters the GvHD/GvT Paradigm after Allogenic Bone Marrow Transplantation.

Journal: Cancer research

Published: October 05, 2018

Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo.

Journal: Journal of medicinal chemistry

Published: June 29, 2018

OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics.

Journal: Journal of immunology research

Published: April 10, 2018

Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras.

Journal: Cancer immunology, immunotherapy : CII

Published: July 03, 2017